AGP Picks
View all

Wyoming Tech Reporter
Provided by AGP

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 27, 2026

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
May 27, 2026

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen

Indeterminate GlobeNewswire
Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026
May 27, 2026

Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026

Indeterminate GlobeNewswire
Quantum Cyber Files Provisional Patent Application for Coaxial Dual-Propellant Grain Solid Rocket Motor Designed to Extend Range and Loiter Time of Defense UAVs
May 27, 2026

Quantum Cyber Files Provisional Patent Application for Coaxial Dual-Propellant Grain Solid Rocket Motor Designed to Extend Range and Loiter Time of Defense UAVs

Indeterminate GlobeNewswire
Charles IT Named a 2026 Best and Brightest Company to Work For® Nationally and in New England
May 27, 2026

Charles IT Named a 2026 Best and Brightest Company to Work For® Nationally and in New England

Indeterminate GlobeNewswire
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
May 27, 2026

Transforming Rural Health Care Through a First-of-its-Kind Collaborative

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 27, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

Indeterminate GlobeNewswire
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
May 27, 2026

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

Indeterminate GlobeNewswire
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 27, 2026

Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease

Indeterminate GlobeNewswire
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
May 27, 2026

Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming Investor Events
May 27, 2026

Invivyd to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
Climb Announces North American Distribution Partnership with Quantum
May 27, 2026

Climb Announces North American Distribution Partnership with Quantum

Indeterminate GlobeNewswire
Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
May 27, 2026

Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology
May 27, 2026

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

Indeterminate GlobeNewswire
Intchains Group to Present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on June 3-4
May 27, 2026

Intchains Group to Present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on June 3-4

Indeterminate GlobeNewswire
RevEng.AI raises $15 million to verify the security and integrity of AI-generated software
May 27, 2026

RevEng.AI raises $15 million to verify the security and integrity of AI-generated software

Indeterminate GlobeNewswire
Satellos to Participate in Upcoming Investor Conferences
May 27, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026
May 27, 2026

Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Wyoming Tech Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.